A molecular key for delaying the progression of multiple sclerosis is found

July 23, 2018, University of the Basque Country
Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

Multiple sclerosis (MS) is an autoimmune disease that attacks and destroys the myelin sheath that insulates nerve cells. Current treatment is based on modulating the activity of the immune system or preventing immune cells from accessing the central nervous system and damaging it. These therapies are effective in the early phases of the disease, but they do not prevent its advance and the associated progressive functional deterioration.

During the progressive phase of the disease, the microglial cells in the brain are the main cause of the chronic inflammation responsible for neurological deterioration. These microglial cells are the brain's sentries, reacting when faced with damage or infection. This reaction, which is in principle beneficial, becomes harmful when it is prolonged over time, leading to , aggravating the disease and encouraging its progression.

In the work just published, it was possible to identify a receptor known as P2X4 present in the that increases their anti-inflammatory potential in order to reduce the damage in multiple sclerosis and encourage the body's own repair responses. This experimental development was conducted using animal models of MS, thanks to which it was possible to discover that the drugs that activate this receptor improve the symptoms during the chronic phase of the disease when furthering the repair of the nervous tissue.

Dr. María Domercq of the UPV/EHU's Department of Neurosciences and who works at the ACHUCARRO centre for research in Leioa (Basque Country) says, "We are witnessing a discovery that is opening up a new channel of pharmacological development for the treatment of the progressive phase of multiple sclerosis, and with it we want to open a new door on improving the life quality of people who suffer ."

Explore further: Chemical compound produces beneficial inflammation, remyelination that could help treat MS

More information: Alazne Zabala et al, P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis, EMBO Molecular Medicine (2018). DOI: 10.15252/emmm.201708743

Related Stories

Chemical compound produces beneficial inflammation, remyelination that could help treat MS

May 29, 2018
Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people worldwide, alter the body's immune system to reduce disease symptoms and disability.

Cellular self-digestion process triggers autoimmune disease

December 13, 2017
Autophagy refers to a fundamental recycling process of cells that occurs in yeast, fungi, plants, as well as animals and humans. This process allows cells to degrade their own components and thus activate energy resources ...

Researchers report novel complementary effects of estrogen treatment in multiple sclerosis

December 28, 2017
A study by UCLA researchers reveals the cellular basis for how the hormone estrogen protects against damage to the central nervous system in people with multiple sclerosis (MS). The researchers found that estrogen treatment ...

Potential new approach to the treatment of multiple sclerosis

March 5, 2018
A prospective new method of treating patients with multiple sclerosis has been proposed by researchers of the Mainz University Medical Center working in cooperation with researchers of the University of Montreal. In model ...

Antidepressant may help combat the course of multiple sclerosis

December 20, 2017
The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remissions. As yet, drugs for this type of MS have been ...

New blood cells fight brain inflammation

February 16, 2014
Hyperactivity of our immune system can cause a state of chronic inflammation. If chronic, the inflammation will affect our body and result in disease. In the devastating disease multiple sclerosis, hyperactivity of immune ...

Recommended for you

How returning to a prior context briefly heightens memory recall

December 11, 2018
Whether it's the pleasant experience of returning to one's childhood home over the holidays or the unease of revisiting a site that proved unpleasant, we often find that when we return to a context where an episode first ...

The importins of anxiety

December 11, 2018
According to some estimates, up to one in three people around the world may experience severe anxiety in their lifetime. In a study described today in Cell Reports, researchers at the Weizmann Institute of Science have revealed ...

Neurons in the brain work as a team to guide movement of arms, hands

December 11, 2018
The apparent simplicity of picking up a cup of coffee or turning a doorknob belies the complex sequence of calculations and processes that the brain must undergo to identify the location of an item in space, move the arm ...

The richer the reward, the faster you'll likely move to reach it, study shows

December 11, 2018
If you are wondering how long you personally are willing to stand in line to buy that hot new holiday gift, scientists at Johns Hopkins Medicine say the answer may be found in the biological rules governing how animals typically ...

Study: Age, race differences determine risk of stroke in women and men

December 11, 2018
A new study found that, between the ages of 45 and 74 years, white women were less likely to have a stroke than white men, but at age 75 and older, there was no difference in stroke risk between white women and men. In contrast, ...

Using neurofeedback to prevent PTSD in soldiers

December 11, 2018
A team of researchers from Israel, the U.S. and the U.K. has found that using neurofeedback could prevent soldiers from experiencing PTSD after engaging in emotionally difficult situations. In their paper published in the ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Anonym926821
not rated yet Jul 30, 2018
I was on Copaxone, the first year was daily and later was 40 mg, 3 times a week. It didn't make a tremendous difference for me. I've tried therapy, but it is not helping. I was seeking something to help regain my life to be able to do things for myself. It is frustrating when it feels like nobody is trying to help you find some relief. March this year after reading a lot of positive reviews online about a Natural Herbal Gardens My primary physician suggested I started Natural herbal treatment, I ordered the herbal formula and I am glad to report the herbal formula worked effectively and there was no side effects, I had a total decline in symptoms, the joints pain, weakness and other symptoms stopped, my MS is totally REVERSED, Here

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.